Overcoming Drug Resistance in Gynecologic Cancers

Volume editor:   Riyaz Basha (Associate Professor Department of Pediatrics and Women’s Health University of North Texas Health Science Center (UNTHSC) USA), Sarfraz Ahmad, PhD. (University of Alabama, Birmingham, AL, USA.)
Imprint:   Academic Press Inc
Country of Publication:   United States
Dimensions:   Height: 235mm,  Width: 191mm, 
Weight:   950g
ISBN:   9780128242995
ISBN 10:   012824299X
Series:   Cancer Sensitizing Agents for Chemotherapy
Pages:   388
Publication Date:   17 August 2021
Audience:   Professional and scholarly ,  Undergraduate
Format:   Hardback
Publisher's Status:   Active

Doctor Riyaz Basha is an Associate Professor & Vice Chair for Research in the Department of Pediatrics and Women’s Health, Texas College of Osteopathic Medicine, The University of North Texas Health Science Center (UNTHSC) at Fort Worth, TX, USA. He graduated with a PhD degree in 1999 from the Sri Venkateswara University, Tirupati, India, and received postdoctoral training at the University of Rhode Island, RI, USA. Before joining the UNTHSC in 2013, Dr. Basha was appointed as an Assistant Professor at the Cancer Research Institute of the MD Anderson Cancer Center at Orlando (currently named as UF Cancer Center), Orlando, FL, USA. Dr. Basha’s research is focused on improving cancer therapies in children, adolescents and adults. He has been working closely with physicians and researchers with emphasis on the translational principle of “bench to bedside”. He has been investigating on drug resistance and novel strategies to improve the response of standard care/treatment, especially chemotherapy for various cancers including ovarian cancer. He has published his research findings in high impact factor journals such as Journal of Biological Chemistry, Cancer Letters, Cancer Medicine, Critical Reviews in Oncology/Hematology, and Gynecologic Oncology. Dr. Basha is a member of several scientific societies, including the Association of Biotechnology and Pharmacy (ABAP), American Association for Cancer Research, American Society of Clinical Oncology, and American Association for Clinical Chemistry (AACC) Academy. He became Fellow of the ABAP and the AACC Academies, respectively, in 2014 and 2019. He is the recipient of numerous competitive grants from the National Institutes of Health, Hyundai Hope On Wheels, non-profit foundations, and awards including the Young Scientist Travel Award from the Asian Pacific Society for Neurochemistry, four research presentation awards from the Society of Toxicology (USA), and the best presentation award at the International Conference on Drug Discovery and Therapy held in Dubai, UAE. Dr. Basha co-authored more than 100 peer-reviewed publications, served as Guest Editor for two journals, and serving as peer reviewer for more than 50 scientific journals. His research works are extensively cited by the peers globally. Prof. Ahmad S is Director of Clinical Research at AdventHealth Cancer Institute (AHCI), Orlando, FL, USA. He earned his PhD in Biochemistry from North-Eastern Hill University, Shillong. Prof. Ahmad’s research focus is on the analyses of clinico-pathologic and surgical outcomes of oncology, hematology, and gastroenterology (GI) patients and to better understand the cellular/molecular mechanisms of cancer and related thromboembolic/hematologic disorders. Prof. Ahmad has published over 250 peer-reviewed scholarly research articles and book chapters, and over 400 scientific abstracts. He is a reviewer and has editorial responsibilities for several biomedical journals and books; and has received competitive research grants and national/international awards for his research contributions/accomplishments